Clinical trial
Effectiveness Study of Dronabinol and BRENDA for the Treatment of Cannabis…
NCT00480441 · University of Pennsylvania, Other · Completed
Key facts
| NCT number | NCT00480441 |
|---|---|
| Title | Effectiveness Study of Dronabinol and BRENDA for the Treatment of Cannabis Withdrawal |
| Official title | A Phase II Double-Blind Placebo-Controlled Trial of Dronabinol and BRENDA for the Treatment of Cannabis Withdrawal |
| Lead sponsor | University of Pennsylvania, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Marijuana Dependence |
| Intervention type | Behavioral, Drug |
| Interventions | Dronabinol, BRENDA therapy, Placebo |
| Enrollment | 61 |
| Start date | Aug 1, 2006 |
| Primary completion | Jun 1, 2009 |
| Completion | Jul 1, 2009 |
| First posted | May 31, 2007 |
| Last update posted | Jul 29, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: